Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.
about
Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia BThe use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A.Population pharmacokinetics of plasma-derived factor IX: procedures for dose individualization.Partnering to change the world for people with haemophilia: 6(th) Haemophilia Global Summit, Prague, Czech Republic, 24-26(th) September 2015.Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?Managing Haemophilia for Life: 5th Haemophilia Global Summit.
P2860
Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacokinetics of plasma-der ...... ling data needs further study.
@ast
Pharmacokinetics of plasma-der ...... ling data needs further study.
@en
type
label
Pharmacokinetics of plasma-der ...... ling data needs further study.
@ast
Pharmacokinetics of plasma-der ...... ling data needs further study.
@en
prefLabel
Pharmacokinetics of plasma-der ...... ling data needs further study.
@ast
Pharmacokinetics of plasma-der ...... ling data needs further study.
@en
P2860
P356
P1433
P1476
Pharmacokinetics of plasma-der ...... ling data needs further study.
@en
P2093
E Berntorp
P2860
P304
P356
10.1111/HAE.12277
P577
2013-11-01T00:00:00Z